GM2-gangliosidosis: clinical, pathological, and biochemical studies on 8 patients. Eight cases of late onset Gm,-gangliosidosis are described. 4 presented before the age of 2 years and 4 between 3j and 10 years. Gait disturbance, intellectual deterioration, and fits were prominent features. Optic atrophy was seen at a late stage in 2 patients. An exaggerated startle reaction to sound and an unusual type of cherry red spot at the macula were seen for the first time in this condition. Pathological changes were similar to those described in Tay-Sachs disease. There was an increase in the amount of a ganglioside chromatographically identical with that found in Tay-Sachs disease. A partial deficiency of hexosaminidase A was found in 2 cases and a profound deficiency in 4. There was no correlation between the age of onset of symptoms and the degree of enzyme deficiency. The evidence presented is consistent with an autosomal recessive mode of inheritance.
When the lipid which accumulates in brains of patients with Tay-Sachs disease was characterized as the ganglioside GM, (Svennerholm, 1962) , the name 'GMf-gangliosidosis' was introduced and came to be used interchangeably with the clinical term (Suzuki and Chen, 1967) . From the structure of ganglioside GM2 it was inferred that the enzyme hexosaminidase would be involved in its normal degradation and that a deficiency of this enzyme would account for the storage of the ganglioside in patients with Tay-Sachs disease. However, normal levels of hexosaminidase activity were found in tissues from patients until Sandhoff, Andreae, and Jatzkewitz (1968) described a clinically typical case of Tay-Sachs disease in which hexosaminidase activity was absent.
After the demonstration by Robinson and Stirling (1968) that hexosaminidase activity can be resolved into two components, A and B, it was found that component A alone was absent from the tissues of most patients with Tay-Sachs disease (Okada and O'Brien, 1969; Sandhoff, 1969; Hultberg, 1969) . Component B was increased to Received 7 April 1973. such an extent that total hexosaminidase activity fell within the normal range or was even raised. Sandhoff (1969) has described a third form of Tay-Sachs disease with the typical clinical features but with normal activity of both hexosaminidase components when the standard methylumbelliferyl substrate was used.
The complexity of the GM,-gangliosidosis group of disorders has become increasingly apparent with the recognition of forms clinically distinct from Tay-Sachs disease. These have been described as 'late-infantile' and 'juvenile' G.,-gangliosidosis, since the onset of symptoms occurs later and deterioration is less rapid. 6 cases have been reported by others (see Table I (Young et al., 1970 (1968, 1971) .
Case 7. A female was the third child of healthy unrelated parents. The pregnancy, delivery, newborn period, and motor milestones were normal. Sentences were first spoken at the age of 3. She had always run awkwardly and her gait was noticed to be unsteady at 4j. At 5j she developed a stutter and seemed to forget what she wanted to say. At the age of 5 she could write her name and do simple sums, but at school was described as naughty, wilful, and difficult to handle.
At 6l psychometric assessment showed IQ of 85 (verbal) and 89 (performance) and she was later seen by a child psychiatrist because emotional problems were suspected. By 7 years she had ceased to learn and thereafter deteriorated in all skills. At 9 she moved to a school for educationally subnormal children. After this she deteriorated more rapidly. She became doubly incontinent, was afraid to climb stairs, and would ask her parents which foot to put first. She lost all interest in games, spending her time watching television, but not remembering anything about the programmes. Later she stopped feeding herself. Her hearing and vision seemed normal. Cryostat sections of rectal biopsies (from Cases 2, 3, 7, and 8) were stained as described by Bodian and Lake (1963) . Each biopsy contained enlarged vacuolated neurons which stained intensely with PAS (Fig. 2) and Buxton et al. (1972) .
Chemistry. Lipid extracts were prepared as described by Neville et al. (1973) from brain cortex in Cases 1, 2, 3,* and 6,* and from rectal tissue from Case 8. Thin-layer chromatography of the brain extracts showed a marked excess of a substance with the mobility and properties of ganglioside GM2, though the excess was not as marked as that seen in Tay-Sachs disease (Fig. 3) . Though the brain from Case 1 had been in formalin for 5 years before extraction, there was evidence of an excess of ganglioside GM2. The ganglioside *Cases 3 and 6 were examined by Professor J. N. Cumings of the National Hospital, Queen Square, London. showed an excess of ganglioside GM2 in Case 8 (Fig. 4) .
Enzyme studies. Four methods have been used to distinguish between the components of hexosaminidase activity in tissue extracts and body fluids: starch-gel electrophoresis, heat-inactivation, ion-exchange chromatography, and iso-electric focusing (Robinson, Price, and Dance, 1967; Okada and O'Brien, 1969; Sandhoff, 1969; O'Brien et al., 1970; Young et al., 1970) . Hexosaminidase components were originally defined as bands of activity visualized after electrophoresis on starch-gel (Robinson and Stirling, 1968) , and care should be taken in interpreting quantitative results when other techniques are used.
The proportion of the total hexosaminidase activity present as the heat-labile component (approximately equivalent to the electrophoretic component A) in leucocytes, fibroblasts, and tissues was determined as described by Buxton et al. (1972) with the following modifications. Heat-inactivation was carried out at 47*5°C for 3 hours and 0-2% human serum albumin (Sigma Fraction V) was incorporated into the McIlvaine's citric acid-sodium phosphate buffer, pH 4-5 used for diluting tissue extracts. Heat-labile hexosaminidase activity in serum and plasma was estimated by the method of O'Brien et al. (1970) , except the buffer used was that described above and the methylumbelliferyl glucosaminide concentration was 1-5 mmol/l. in the final incubation medium.
Previously reported studies on the proportion of hexosaminidase component A in four cases of late onset Gm2-gangliosidosis are summarized in Table I , and the results on 6 of the patients described in this report are given in Table II . It can be seen that of the 10 cases in which enzyme studies have now been reported, 4 have a partial deficiency of hexosaminidase component A (30 to 40% of the total hexosaminidase activity present as component A) and 6 have a profound deficiency (0 to 13% of total activity).
Discussion
As implied by the name Gm,-gangliosidosis, the factor common to all types is the excessive accumulation of the ganglioside GM2. They also share certain characteristic histological and electron microscopical features, but they may be subdivided either by clinical criteria or by the pattern of deficiency in the components of hexosaminidase. useful criteria in classifying the GM,-gangliosidoses.
The commonest form of this condition is TaySachs disease in which symptoms appear in the 'infantile' period (within the first 8 months). Typical presenting features of Tay-Sachs disease include an abnormal startle response to sound, cherry red spots at the maculae, and failure in motor development with weakness and hypotonia. Deterioration is rapid. Fits usually begin at about 1 year. Megalencephaly often becomes apparent during the second year, and by the age of 2 the patient is in a vegetative state, blind, and hypertonic; frequent fits and decerebrate posturing are common. Death usually occurs between 2 and 4 years of age. Though clinically indistinguishable, three types of Tay-Sachs disease have been recognized by studies on the components of hexosaminidase, as described in the introduction.
In contrast to cases of Tay-Sachs disease, the early development of our 8 patients with the late onset forms of Gm,-gangliosidosis was normal.
Cherry red spots at the maculae and an abnormal startle reaction, characteristic of Tay-Sachs disease, were seen in 3 patients, though the appearance of the cherry red spots was unlike that seen in cases of Tay-Sachs disease (see Fig. 1 In the fourth juvenile case the onset of symptoms was insidious and hence difficult to date precisely, but it was probably not earlier than the ninth year. This is much later than in any previously described case. This patient developed seizures about 1 year from the start of symptoms and died 4 years later.
Only 2 children with the juvenile form have previously been reported. The case of died at the age of 15, 10 years from onset, having had fits for 7 years. The patient reported by Buxton et al. (1972) developed symptoms at about the age of 5 years, and fits began about 2 years later. He was still alive about 41 years from onset.
It is possible that the differentiation into lateinfantile and juvenile categories will disappear as new cases are described.
Cases of late onset Gm2-gangliosidosis may alternatively be subdivided according to the degree of the enzyme deficiency. They fall into two groups: one in which the deficiency may be described as partial, and another in which it is profound and similar to that found in the common form of Tay-Sachs disease. Of the 10 cases in which enzyme studies have been performed (including 6 in the present study), 4 were found to have a partial deficiency, and in 6 it was profound. This marked difference in the degree of deficiency of the enzyme may reflect a fundamental difference in the nature of the biochemical lesion.
There appears to be no correlation between the age of onset of symptoms and the degree of deficiency of hexosaminidase component A when assayed using the synthetic methylumbelliferyl substrate. The level of hexosaminidase A in cases with the partial deficiency is, moreover, similar to that of carriers for the more common form of Tay-Sachs disease. Though the use of the natural lipid substrate may increase our understanding of the basic defect, the variable clinical features of this disease will probably not be explained until the primary structure of hexosaminidase and the metabolic relations between its component forms are known.
An automsomal recessive mode of inheritance suggested by Okada et al. (1970) is substantiated by the study of our 8 cases. Among the total of 14 cases there have been 4 pairs of affected sibs; normal sibs were found in several families; males and females were affected and, in some cases at least, the parents of affected children have relatively reduced levels of hexosaminidase A. For families in which a child with the profound deficiency has been diagnosed, it seems likely that prenatal detection of an affected fetus will be reliable. 
